# SurgiQ s.r.l.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/surgiq-s-r-l

- Industry: Software
- Headquarters: Genoa, Italy
- Website: www.surgiq.com
- Total disclosed funding: $0.5M
- Latest round: Seed (Jan 26, 2021)
- Investors on record: 2

## About

SurgiQ s.r.l. is a healthcare technology company focused on enhancing hospital and clinic operations through advanced artificial intelligence solutions, aimed at optimizing efficiency and improving patient management.Founded in 2012 and headquartered in Genoa, Italy, SurgiQ specializes in developing innovative solutions for healthcare management. The company has completed 2 deals, with its latest funding round being a Seed round of EUR 410,000 raised on January 26, 2021, from investors including CDP Venture Capital and Digital Magics. The founding team includes Ivan Porro and Luca Corradi, with Ivan Porro currently serving as CEO.SurgiQ specializes in providing advanced healthcare management solutions primarily driven by artificial intelligence technology. Their core offerings include a platform designed to streamline hospital and clinic operations by automating key processes and enhancing organizational efficiency. The platform supports real-time planning and monitoring, facilitating smoother patient flows and reducing the likelihood of errors in healthcare delivery. Notable clients include Bambino Gesù Pediatric Hospital, which utilizes SurgiQ to optimize waiting list management, and ICS Maugeri, which employs QRehab for addressing complex rehabilitation pathways. SurgiQ's products are deployed across various healthcare institutions in Italy and potentially extend to international markets, focusing on improving service delivery and operational performance in hospitals and clinics.In 2023, SurgiQ generated revenue of EUR 256,343.60. The company reported an EBITDA of EUR -57,289 for the same year. SurgiQ generates revenue through B2B transactions with healthcare institutions, leveraging subscription-based models for access to its suite of products and services. Clients typically engage in contractual agreements that may include tailored service plans based on their specific operational needs. The platform's capabilities are designed to enhance communication among healthcare providers, improve patient management, and facilitate the digitalization of administrative tasks. This structure not only fosters long-term partnerships with institutions like Ospedali Galliera and IRCCS San Martino but also promotes a comprehensive approach to healthcare efficiency.SurgiQ plans to leverage its recent Seed funding of EUR 410,000 raised in January 2021 to strengthen strategic partnerships with the University of Genoa (Dibris) and a major pharmaceutical company for the development of new product features. The company is currently focused on expanding its products and services in the Italian market, with potential plans to enter other European regions by 2024.

## Funding rounds

- Seed, Jan 26, 2021, $0.5M — CDP Venture Capital, Digital Magics

## Investors

- CDP Venture Capital (https://capitalatlas.ai/funds/cdp-venture-capital) — Seed
- Digital Magics (https://capitalatlas.ai/funds/digital-magics) — Seed